Evidence map›Paper›PMID 31269442›Full record

ArticleCell reports2019

Nitric Oxide Modulates Metabolic Remodeling in Inflammatory Macrophages through TCA Cycle Regulation and Itaconate Accumulation.

Jade D Bailey, Marina Diotallevi, Thomas Nicol, Eileen McNeill, Andrew Shaw, Surawee Chuaiphichai, Ashley Hale, Anna Starr, Manasi Nandi, Elena Stylianou and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 171 papers.

0numbers the graph read from it
0cells of the map it votes in
171citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

171 citing papers in PubMed, 253 citations in OpenAlex.

  1. Review
  2. LC-MS/MS Chemical Profiling and HPLC/PDA Quantification ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Molecular pharmaceutics · 2026
    Article
  12. Article
  13. Article
  14. The osteoclast intracellular environment fosters bacterial growth duringbioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Timing of Glucocorticoid Treatment Dictates Glucocorticoid Receptor Actions Modulating the NLRP3-Inflammasome Activation in Macrophages.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  17. HAPI Cells are SIM-A9-related Mouse Microglial Cells Useful forbioRxiv : the preprint server for biology · 2026
    Article
  18. Article
  19. Article
  20. Dysregulated immunometabolism in gut inflammation.Acta biochimica et biophysica Sinica · 2026
    Review

111 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Jade D BaileyBHF Centre of Research Excellence, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Marina DiotalleviBHF Centre of Research Excellence, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Thomas NicolBHF Centre of Research Excellence, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Eileen McNeillBHF Centre of Research Excellence, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Andrew ShawBHF Centre of Research Excellence, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Surawee ChuaiphichaiBHF Centre of Research Excellence, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Ashley HaleBHF Centre of Research Excellence, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Anna StarrSchool of Cancer and Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, London SE1 9NH, UK.
Manasi NandiSchool of Cancer and Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, London SE1 9NH, UK.
Elena StylianouJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.
Helen McShaneJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.
Simon DavisTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK.
Roman FischerTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK.
Benedikt M KesslerTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK.
James McCullaghChemistry Research Laboratory, Department of Chemistry, University of Oxford, Mansfield Road, Oxford OX1 3TA, UK.
Keith M ChannonBHF Centre of Research Excellence, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK. Electronic address: keith.channon@cardiov.ox.ac.uk.
Mark J CrabtreeBHF Centre of Research Excellence, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK. Electronic address: mark.crabtree@well.ox.ac.uk.
University of Oxford · GBJohn Radcliffe Hospital · GBKing's College London · GBJenner Institute · GB

Funding

British Heart Foundation FS/14/56/31049British Heart Foundation RE/13/1/30181British Heart Foundation RE/18/3/34214British Heart Foundation RG/07/003/23133British Heart Foundation RG/12/5/29576British Heart Foundation RG/17/10/32859Wellcome TrustWellcome Trust 090532/Z/09/Z
6 · The paper itself

Abstract

Classical activation of macrophages (M(LPS+IFNγ)) elicits the expression of inducible nitric oxide synthase (iNOS), generating large amounts of NO and inhibiting mitochondrial respiration. Upregulation of glycolysis and a disrupted tricarboxylic acid (TCA) cycle underpin this switch to a pro-inflammatory phenotype. We show that the NOS cofactor tetrahydrobiopterin (BH

Indexed as

Citric Acid CycleAnimalsBiopterinsElectron TransportEndotoxemiaGlycolysisGTP CyclohydrolaseInflammationInterferon-gammaInterleukin-1betaIsocitrate DehydrogenaseLipopolysaccharidesMacrophage ActivationMacrophagesMiceMice, KnockoutBiopterinsGTP CyclohydrolaseIdh1 protein, mouseInterferon-gammaInterleukin-1betainterleukin-1beta (163-171)Isocitrate Dehydrogenaseitaconic acidLipopolysaccharidesNitric OxideNitric Oxide Synthase Type IINos2 protein, mousePeptide FragmentsProteomesapropterinSuccinatesSuccinic Acidimmunometabolisminflammationmacrophage metabolismmitochondrianitric oxidetetrahydrobiopterin

Identifiers

PMID31269442
PMCPMC6616861
OpenAlexW2953598628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.